Latest Breaking News On - Clinical oncology genitourinary cancers - Page 1 : comparemela.com

Top Causes of Early Noncancer Deaths in Advanced GU Cancers

Sepsis was the leading reason for early noncancer deaths in patients with metastatic bladder, kidney, or prostate cancer, a recent analysis found.

New yorkUnited statesAhsan ayazEnd resultsPacific islandersCornwall hospitalClinical oncology genitourinary cancersProstate carcinomaAlignant prostate neoplasmProstate cancerAncer of the prostateBloodstream infectionsRenal diseaseKidney diseaseKidney disorderRenal disorder

Pembrolizumab Improves Disease-Free Survival for Muscle-Invasive Urothelial Carcinoma

The late-breaking data at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium included the results of KEYNOTE-123 for locally advanced resectable urothelial carcinoma.

United statesNational cancer instituteMerck research laboratoriesNational institutes of healthClinical oncology genitourinary cancersAfter surgeryLocalized muscle invasive bladder cancerLocally advanced urothelialNational cancerCompletion dateBladder cancer sectionGenitourinary malignancies branchNational institutes

Time for Universal Genetic Testing in Genitourinary Cancers

A new study supported universal germline genetic testing for genitourinary cancers to enhance risk assessment and guide tailored interventions.

United statesMouneeb choudryNational comprehensive cancer networkDepartment of urologyMayo clinicMayo clinic arizonaClinical oncology genitourinary cancersMalignant kidney neoplasm renal cell cancer rcc carcinoma of theRenal cell carcinomaGenomics genomic medicineAlignant neoplasiaAlignant neoplasmKidney cancerAdrenal cancerProstate carcinomaAlignant prostate neoplasm

Bristol Myers reveals subcutaneous Opdivo data in kidney cancer

Bristol Myers reveals subcutaneous Opdivo data in kidney cancer
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesRob davisBristol myers squibbClinical oncology genitourinary cancersHealthcare conference

Merck s Keytruda extends life for kidney cancer patients after surgery, while Bristol s Opdivo fails again

Merck s Keytruda extends life for kidney cancer patients after surgery, while Bristol s Opdivo fails again
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesRoche tecentriqMerck research laboratoriesBristol myers squibbClinical oncology genitourinary cancers